- Home
- CODX vs SRZN Comparison
CODX vs SRZN Comparison
Compare CODX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- SRZN
- Stock Information
- Founded
- CODX 2013
- SRZN 2015
- Country
- CODX United States
- SRZN United States
- Employees
- CODX N/A
- SRZN N/A
- Industry
- CODX Medical/Dental Instruments
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- CODX Health Care
- SRZN Health Care
- Exchange
- CODX Nasdaq
- SRZN Nasdaq
- Market Cap
- CODX 42.8M
- SRZN 25.8M
- IPO Year
- CODX 2017
- SRZN N/A
- Fundamental
- Price
- CODX $1.34
- SRZN $9.23
- Analyst Decision
- CODX Hold
- SRZN
- Analyst Count
- CODX 1
- SRZN 0
- Target Price
- CODX $1.50
- SRZN N/A
- AVG Volume (30 Days)
- CODX 611.5K
- SRZN 13.0K
- Earning Date
- CODX 08-08-2024
- SRZN 08-12-2024
- Dividend Yield
- CODX N/A
- SRZN N/A
- EPS Growth
- CODX N/A
- SRZN N/A
- EPS
- CODX N/A
- SRZN N/A
- Revenue
- CODX $9,136,969.00
- SRZN N/A
- Revenue This Year
- CODX N/A
- SRZN N/A
- Revenue Next Year
- CODX N/A
- SRZN N/A
- P/E Ratio
- CODX N/A
- SRZN N/A
- Revenue Growth
- CODX 25.24
- SRZN N/A
- 52 Week Low
- CODX $0.98
- SRZN $4.50
- 52 Week High
- CODX $2.23
- SRZN $16.19
- Technical
- Relative Strength Index (RSI)
- CODX 49.20
- SRZN 53.71
- Support Level
- CODX $1.25
- SRZN $9.03
- Resistance Level
- CODX $1.58
- SRZN $10.75
- Average True Range (ATR)
- CODX 0.27
- SRZN 0.82
- MACD
- CODX -0.03
- SRZN 0.20
- Stochastic Oscillator
- CODX 9.18
- SRZN 58.99
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).